Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03955471
Title Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Participants With Platinum Resistant Ovarian Cancer (MOONSTONE)
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Tesaro, Inc.

ovarian clear cell carcinoma

ovarian serous carcinoma

endometrioid ovary carcinoma

fallopian tube cancer

peritoneum cancer


Dostarlimab-gxly + Niraparib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.